Peptide Interaction Matrix
Comprehensive compatibility guide for combining research peptides
Synergistic
Complementary pathway signaling
Compatible
No known pathway interference
Caution
Monitor closely
Avoid
Not recommended
BPC-157 | TB-500 | CJC-1295 NO DAC | Ipamorelin | GHRP-6 | Melanotan II | GHK-Cu | KPV | Semax | Selank | NAD+ | HCG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BPC-157 | ||||||||||||
| TB-500 | ||||||||||||
| CJC-1295 NO DAC | ||||||||||||
| Ipamorelin | ||||||||||||
| GHRP-6 | ||||||||||||
| Melanotan II | ||||||||||||
| GHK-Cu | ||||||||||||
| KPV | ||||||||||||
| Semax | ||||||||||||
| Selank | ||||||||||||
| NAD+ | ||||||||||||
| HCG |
BPC-157 + TB-500
Complementary tissue-signaling mechanisms studied in research models. Localized + systemic pathways.
CJC-1295 + Ipamorelin
Dual-receptor GH axis signaling. GHRH + Ghrelin pathway research in test subjects.
Semax + Selank
Complementary neurotrophic signaling pathways. BDNF and GABAergic receptor research in test subjects.
Synergistic Combinations
These peptides act through complementary signaling pathways and are frequently studied together in research protocols to observe combined pathway activation.
Compatible Combinations
These peptides act through different mechanisms and no pathway interference has been observed in available research literature.
Caution Combinations
These combinations involve overlapping signaling pathways and may require adjusted research parameters. Not necessarily contraindicated, but warrant careful protocol design.
Timing Considerations
Research protocols may specify timing parameters for certain peptides. See our Stacking Guide for detailed research protocol considerations.
Research Use Only
This interaction matrix is based on available research literature and is provided for educational purposes only. All peptides are for laboratory research use only. Individual responses may vary. Always follow proper research protocols and safety guidelines.